MedPath

Polyethylene glycol 400

Generic Name
Polyethylene glycol 400
Brand Names
Blink Tears, Colirio Ocusan, Leader Lubricant Eye Drops, QC ultra lubricant eye, Systane, Tears Lubricant, Visine Dry Eye Relief
Drug Type
Small Molecule
CAS Number
25322-68-3
Unique Ingredient Identifier
B697894SGQ
Background

Polyethylene glycols (PEGs) are products made of condensed ethylene oxide and water that can contain various derivatives and have various functions. Because many PEG types are hydrophilic, they are favorably used as enhancers of penetration, and used heavily in topical dermatological preparations. PEGs, along with their many nonionic derivatives, are widely utilized in cosmetic products as surfactants, emulsifiers, cleansing agents, humectants, and skin conditioners.

Polyethylene glycol 400 (PEG 400) is a low-molecular-weight grade of polyethylene glycol with a low-level toxicity. It is very hydrophilic, which renders it a useful ingredient in drug formulations to augment the solubility and bioavailability of weakly water-soluble drugs. It is used in ophthalmic solutions for the relief of burning, irritation and/or discomfort that follows dryness of the eye . PEG "400" indicates that the average molecular weight of the specific PEG is 400 .

PEGylation occurs when PEGs are attached to numerous protein medications, allowing for greater solubility for selected drugs. Examples of PEGylated medications are PEG-interferon alpha (Pegintron) and PEG-filgrastim. In addition, PEG is available as a bowel preparation for colonoscopy procedures and as a laxative .

Indication

PEG-400 has been indicated for the temporary relief of burning and irritation due to dryness of the eye, andfor protection against further irritation and desiccation , , .

Associated Conditions
Constipation, Dry Eyes

Efficacy of PEG-400 and Systane Artificial Tears (Alcon) on Quality of Vision

Phase 4
Completed
Conditions
Myopia
Interventions
First Posted Date
2008-03-03
Last Posted Date
2008-11-24
Lead Sponsor
Bp Consulting, Inc
Target Recruit Count
40
Registration Number
NCT00627302
Locations
🇺🇸

Ophthalmic Consultants of long Island, Rockville Centre, New York, United States

Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality

Phase 4
Completed
Conditions
Dry Eye
Interventions
First Posted Date
2008-02-22
Last Posted Date
2010-02-03
Lead Sponsor
Bp Consulting, Inc
Target Recruit Count
70
Registration Number
NCT00622037
Locations
🇺🇸

Florida Microsurgical Eye Institute, Boynton Beach, Florida, United States

Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms

Not Applicable
Completed
Conditions
Dry Eye Syndrome
Interventions
First Posted Date
2007-11-30
Last Posted Date
2018-11-07
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
20
Registration Number
NCT00565669
Locations
🇺🇸

Medical University of South Carolina, Storm Eye Institute, Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath